SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION Biotech GmbH in Germany, offering the most comprehensive portfolio of custom viral vectors for preclinical and clinical studies, just announced the grand opening of a new office in Cambridge, Massachusetts.
The launch of the US subsidiary is the culmination of a 5 months collaboration, where CYTO Consulting assisted Sirion with all aspects of this complex task and will continue the mutually beneficial collaboration beyond the launch.
Read more about Sirion’s launch in this press release.
Visit CYTO Consulting at www.cytoconsulting.com
Comments